Towards Healthcare Research & Consulting

News

Your Daily Gateway to Essential News in Healthcare, Science, Technology and Business Worldwide

Hengrui and Kailera cleared their path for a new victory
13 February 2026

Hengrui and Kailera cleared their path for a new victory

Introduction Kailera Therapeutics is a leading clinically inspired biopharmaceutical company with its footprint in the healthcare sector since October 2024. The company is dedicated towards increasing the number of future effective therapies in its portfolio for suitable metabolic conditions and ob...

Eurofins Expansion Initiative to Bolster the Business
12 February 2026

Eurofins Expansion Initiative to Bolster the Business

Introduction Eurofins Viracor BioPharma, a division of Eurofin Scientific, a leading bio-analytical tester and service provider, is grounded with its footprint and best-in-class laboratory services from Luxembourg. The company serves its remarkable services for consumer products, pharmaceutical, en...

Bruker's New Platform, a stop for mRNA Drugs and More
12 February 2026

Bruker's New Platform, a stop for mRNA Drugs and More

Introduction Bruker Corporation is a known manufacturer of diagnostic solutions, including analytical-derived solutions. The company’s scientific instruments are the lead face of its business development. Bruker makes space for innovations in materials, cellular and molecular research. The re...

Is Ultragenyx's Gene Therapy close to the Win?
12 February 2026

Is Ultragenyx's Gene Therapy close to the Win?

Introduction Ultragenyx Pharmaceuticals is a well-known biopharmaceutical company, popular for its innovative therapies for debilitating genetic, rare and ultra-rare conditions. From the company’s homeland, Novato, California, the company use numerous modalities like mRNA, small molecules and...

Eli Lilly's $2.4B Acquisition of Orna Therapeutics Signals Bold Step Into In Vivo CAR-T
12 February 2026

Eli Lilly's $2.4B Acquisition of Orna Therapeutics Signals Bold Step Into In Vivo CAR-T

Flashback Eli Lilly is one of the most trusted pharma companies when it comes to developing and commercialising robust and effective drugs. Most recently, the company entered the good, popular frame in the healthcare sector with Zepbound and Mounjaro. Lilly's spectacular advancements included its f...

Lilly and Innovent came together for two extreme fields medicines
11 February 2026

Lilly and Innovent came together for two extreme fields medicines

Introduction Innovent Biologics Inc. is a known integration-capable biopharmaceutical company operating in the development, manufacturing and marketing of effective innovative drugs for eye, metabolic, autoimmune and cancer conditions. Innovent has a robust product portfolio, and its popular partne...

Natera's EDEN study on board
11 February 2026

Natera's EDEN study on board

Introduction Natera, Inc., a leading clinical genetic testing company aiming on technologies for better health and organs of women. Since 2003, the company has dedicated its operations to an intensified molecular diagnostics like Panorama, Prospera and Signatera. The company’s precision in th...

CaseBioscience®'s two solutions are ready to contribute to Cell Therapy in the future
11 February 2026

CaseBioscience®'s two solutions are ready to contribute to Cell Therapy in the future

Introduction CaseBioscience®, a registered biotechnology company, is a scholar in advanced media, biopreservation solutions and cGMP-compliant mainly for cell therapy, IVF/ART, regenerative medicine and cell therapy. The company continues its business through its Stem cell Research and Assisted...

The FDA considered Pfizer's review of sBLA in the first place
11 February 2026

The FDA considered Pfizer's review of sBLA in the first place

Introduction Pfizer Inc., a popular multinational biopharmaceutical company with its origins in New York City, aims to discover appropriate vaccines and innovative drugs for immunology, inflammation, and oncology. Pfizer’s significant and most commercialised products include Advil, COVID-19 a...

Akeso's one more Breakthrough Therapy Designation win
10 February 2026

Akeso's one more Breakthrough Therapy Designation win

Introduction Akeso, Inc. is a leading biopharmaceutical company, popular for its full-fledged operation of establishing, manufacturing and marketing effective and creative antibody drugs for conditions like metabolic, immunology and oncology. Along with its exclusive Tetrabody bispecific antibody p...